University of Ioannina
Χημικά τροποποιημένα παράγωγα στεροειδών: σχεδιασμός και ανάπτυξη νέων έξυπνων μέταλλο-φαρμάκων που στοχεύουν εκλεκτικά τα καρκινικά κύτταρα του μαστού
Abstract
dc:descriptionFive new complexes of organotin(IV) and cholic acid (CAH), were synthesized and characterized by melting point, Fourier Transform Infrared Spectroscopy (FT-IR), 119Sn Mössbauer, Nuclear Magnetic Resonance (1H-NMR, 13C-NMR, 119Sn-NMR), Ultraviolet-Visible spectroscopy (UV-Vis), X-ray Fluorescence spectroscopy (XRF), X-ray Powder Diffraction analysis (XRPD), Electron spray Ionization Mass Spectrometry (ESI-MS), High Resolution Mass Spectrometry (HR-MS) and atomic absorption. The formulae of the complexes are Ph3SnCl (1), n-Bu3SnCl (2), Ph2Sn(CA)2 (3), n-Bu2Sn(CA)2 (4) and Me2Sn(CA)2 (5). Furthermore, their stability in solution was examined with UV-Vis and 1H-NMR spectroscopies. Finally their bioactivity studied against normal and breast cancer cell lines.Cholic acid coordinates tin(IV) via the oxygen atom of its carboxylic group. The ratio of cholic acid/organotin(IV) in complexes 1-5 found to be 1:1 for tri-organotin complexes 1-2, while for 3-5 is 2:1. The geometries around tin(IV) atom found to be trigonal bipyramidal for complex 1, tetrahedral for complex 2, while complexes 3-5 appeared to have octahedral geometry. Complexes 1-5 were stable in solution for a week period of time. In order to examine their selective antitumoral activity against breast cancer, their cytotoxicity against MCF-7 (hormone receptor positive) and MDA-MB-231 (hormone receptor negative) breast adenocarcinoma cell lines was calculated by means of Sulforhodamine B assay (SRB). All complexes showed anticancer activity, except for complex 5. Complexes 1-2 showed selective inhibition of MCF-7 cells, while complex 3 inhibits selectively MDA-MB-231 cells. All complexes showed better activity, 4.2-166.9-fold higher, than cisplatin shows against the two breast cancer cell lines. Generally, tri-organotin complexes 1-2 have better activity than di-organotin 3-4. Their cytotoxicity was further examined against the normal fibroblast cell line MRC-5. The IC50 values of 1-5 were higher than those against cancer cell lines. In addition, complexes 2 and 3 have a higher therapeutic potent index (TPI) and therefore reduced toxicity, while all complexes exhibit reduced toxicity compared to cisplatin and organotin chlorides. Their toxicity was also examined in vivo against Artemia salina (brine shrimp) and concluded that they were nontoxic even in concentrations 1.3-25.6-fold higher of the IC50 values. For the evaluation of their genotoxicity both micronucleus (in vitro) and Allium cepa (in vivo) assays were used. Complexes 1-5 did not show genotoxic activity at the IC50 values both in vitro and in vivo. Moreover, in vivo, at concentrations 1.3-25.6-fold higher of the IC50 values, they did not appear to have genotoxic activity. Finally, in order to ascertain their way of action, their ability to inhibit lipoxygenase enzyme (mitochondria), to oxidize linoleic acid (membranes) and binding to DNA (nucleus) was examined. Complexes 1-5 did not inhibit lipoxygenase activity; however, they do oxidize linoleic to hyperoxo-linoleic acid and therefore possibly attack membranes. Another, less possible, way of action is to bind to DNA, because their binding activity towards DNA was found to be weak.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stathopoulou, Maria-Eleni
- Σταθοπούλου, Μαρία-Ελένη
Subjects
dc:subject × 20- Βιολογική ανόργανη χημεία
- Στοχευμένη χημειοθεραπεία
- Καρκίνος του μαστού
- Υποδοχείς ορμονών
- Στεροειδή
- Χολικά οξέα
- Οργανοκασσιτερικές ενώσεις
- Biological inorganic chemistry
- Targeted chemotherapy
- Breast cancer
- Hormone receptors
- Steroids
- Bile acids
- Organotin compounds
- Φυσικές Επιστήμες
- Χημεία
- Βιολογία
- Natural Sciences
- Chemical Sciences
- Biological Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/47615